A Single Session of tDCS (Transcranial Direct Current Stimulation) Improves Endurance for 30 Minutes
NCT ID: NCT03901508
Last Updated: 2020-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-04-05
2019-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary outcome is an isokinetic evaluation of their hamstrings' and quadriceps' strength before and after each session
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Transcranial Direct Current Stimulation Intensity on Leg Muscle Fatigability in Healthy Adults
NCT04321304
Effect of tDCS on Sport Performance for Two Categories of Athletes : Explosive Profile and Enduring Profile
NCT03937115
tDCS in MCS: Repeated Stimulations
NCT02019615
Intensity-Dependent Effects of 4-week Transcranial Direct Current Stimulation on Motor Learning in Healthy Young Adults
NCT07089069
Effects of Dual-site Anodal Transcranial Direct Current Stimulation on Attention, Decision-making and Working Memory During Sports Fatigue in Elite Soccer Athletes
NCT06594978
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each subject came to the Liege University Hospitals' isokinetic lab. Each session began with strapping the subjet into the isokinetic machine, making sure that all the settings were adapted to the subject. Then, each subject underwent a concentric and eccentric isokinetic test of their lower limbs (dominant or non-dominant side depending on their group). Subjects then received either anodal tDCS, of sham tDCS. Neither the evaluator or the subject knew which they were receiving. Immediately following tDCS, there was a another isokinetic test, and 30 minutes after the second test, a subjects underwent a third test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anodal tDCS
Subjects will receive 20min anodal tDCS
TDCS
20 minutes, 2 electrodes (C3/FP2)
Sham tDCS
Subjects will receive 20 minutes of Sham anodal tDCS
TDCS
20 minutes, 2 electrodes (C3/FP2)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TDCS
20 minutes, 2 electrodes (C3/FP2)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right handed and footed
Exclusion Criteria
* Previous neurological or orthopedic pathologies affecting limbs
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Liege
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bornheim Stephen
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Bornheim, Msc
Role: PRINCIPAL_INVESTIGATOR
Liege University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liege Univeristy Hospital
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017/29
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.